Elastography Australia Pricing & ROI for Australian Clinics
Elastography Australia is positioned as a lower-capital guided alternative to FibroScan. Rather than publish one static price that ignores deployment variables, this page shows how clinics should evaluate cost, inclusions, and time to payback.
Price positioning
The commercial story is not just device price. Clinics compare Elastography Australia against FibroScan’s higher capital cost, probe-switching complexity, and the workflow cost of failed scans in obese patients.
Elastography Australia
Guided workflow, single universal probe, lower upfront capital barrier, and clear point-of-care positioning.
FibroScan
Established incumbent with strong brand awareness, but usually higher device cost and multi-probe complexity.
What affects price
- Model tier and deployment footprint
- Training package and onboarding support
- Service and warranty scope
- Commercial structure: purchase, lease, or pay-per-scan
How clinics recoup the investment
The market research shows private scan fees commonly in the $195-$250 range. Combined with a faster 33-second median exam time and lower device cost, the economic case is strongest for clinics that already see MAFLD, diabetes, hepatology, or imaging demand.
Demand
6 million Australians are estimated to be living with MAFLD.
Throughput
33-second median exam times help high-volume clinics improve capacity.
Positioning
Guided imaging and single-probe operation support premium service differentiation.
- Guided liver elastography device with single-probe workflow
- Initial clinical and operator training
- Warranty coverage and ongoing support guidance
- Software updates and reporting setup
- Commercial onboarding for scan workflow and ROI planning
Finance options
The best structure depends on whether the clinic is optimising for cash flow, certainty, or speed to go-live.
Outright Purchase
Best for clinics that want immediate ownership and the lowest long-term financing cost.
Lease-to-Own
Spread capital outlay across predictable monthly payments while bringing the device into service quickly.
Pay-Per-Scan Model
Useful where clinics want to test demand before committing to a traditional capital purchase.
Pricing FAQs
Do you publish a fixed device price online?
No. Pricing depends on model tier, deployment scope, service inclusions, and training requirements, so the page positions value and ROI rather than listing a universal figure.
How does Elastography Australia compare with FibroScan on cost?
The playbook positions Elastography Australia at roughly half the cost of FibroScan while also removing the need for multiple probes, which changes the total cost picture for smaller clinics.
What usually changes the price most?
The biggest factors are model tier, whether the clinic wants expanded support or service coverage, and the commercial structure chosen for financing or ownership.
Why is ROI such a central part of the conversation?
Because liver elastography sits at the intersection of clinical value and service-line economics. Throughput, private scan fees, and future MBS changes all influence time to payback.